secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definium Therapeutics, Inc. (DFTX)
CIK:        0001813814
Form:       8-K
Filed at:   2023-08-14T23:59:59+00:00
Accession:  0000950170-23-042472
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MindMed posts updated investor presentation; no specific updates disclosed in exhibit text
--------------------------------------------------------------------------------

- Filing reports updated corporate presentation posted to website on August 14, 2023.
- Exhibit 99.1 contains only a cover page and legal disclaimer; no pipeline or financial data included.
- Unable to identify material changes without access to full presentation content.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1813814/000095017023042472/0000950170-23-042472-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1813814/000095017023042472/mnmd-20230814.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-042472

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer